MCK had a poor earnings report on October 30th but despite the falling price it still managed to hold the ascending channel. The stock price is right at the gap resistance level but with the stock trying to escape an oversold condition it looks to have a lot more room to rise.
I would be aiming for the resistance line of the ascending channel but $147.20 is the...
I'm very bullish on $MCK and their 2020 plan. The drug distribution company is selling off due to FDA issuing warnings to all distribution companies for shipping "illegitimate" opioid products. I encourage you all to look at the software side of $MCK's business and the McKesson 2020 plan.
As for the charts, Daily TD 9 from Tone Vay's TD indicator + an inverse...
Short-term trade on MCK. The 15m chart shows a clean 5-wave decline from 160 to 142.50, with nice alternation between Wave-2 and Wave-4. A 3-wave correction back into the 50% retracement level offers a good short opportunity. Initiating a short position with an immediate target at 142.50. A move above 157.50 invalidates the setup.
One of the largest pharmaceutical drug distributors covering USA, Canada, Europe.
Showing some bullish signs after coming off a 2 year downtrend, broken out of bearish channel, established priced floor at 135 and moving average cross over.
relatively low PE ratio, beat earnings last 2 quarters with higher earnings projections moving forward according to...
I was listening to a podcast yesterday (We Study Billionaires) and the 2 hosts were talking about how strong the fundamentals are on this company. The technicals are also, pretty good. STRONG pull back here on the monthly and weekly time frames. A dividend payer that's in a buy low, sell high space with SOLID fundamentals (for the long term....)
